Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
YLZ Information Technology Co., Ltd (300096.SZ)
Xiamen, CN
Based in Xiamen, China, and established in 2000, YLZ Information Technology Co., Ltd specializes in delivering IT services for essential public welfare sectors across China. The company's comprehensive solutions cover crucial areas including medical insurance, public health, human resource management, cutting-edge big data innovation, and smart Internet of Things technologies.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.13% | -6.98% | -5.66% | +5.22% | +17.66% | +16.55% | +107.18% | +35.52% | -19.89% | -44.60% | +51.66% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-10.7% Q1'26: +2.6% (vs Q1'25)
-
EPS growth Software - Application: +28.6%+210.0% ★ Q1'26: -5.9% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%+18.4% ★ Q1'26: -145.5% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%+11.0% ★ Q1'26: -56.4% (vs Q1'25)
-
ROIC Software - Application: +7.5%+824.7% ★ Q1'26: -203.0% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.04× ★ Q1'26: -0.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
|---|---|---|
| Revenue |
382.52M
est: 382.52M (+0.0%)
|
279.80M
est: 540.00M (-48.2%)
|
| EBITDA |
109.80M
est: -25.34M (+533.3%)
|
79.72M
est: -35.78M (+322.8%)
|
| EBIT |
103.50M
est: -46.02M (+324.9%)
|
71.41M
est: -64.96M (+209.9%)
|
| Net Income |
86.35M
|
56.24M
|
| SGA |
18.48M
est: 78.78M (-76.5%)
|
74.19M
est: 111.21M (-33.3%)
|
| EPS |
0.20
|
0.13
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 4/5 | 4/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dong Hong Chen | Financial Director & Senior Vice President | — | male |
| Huan Qing Wang | Executive President & Director | — | male |
| Jiangsheng Chen | Senior Vice President | — | male |
| Liang Bin Wu | Chairman & Chief Executive Officer | — | male |
| Niu Niu | Senior Vice President, Board Secretary & Director | — | female |
| Yuan Xing Su | Accounting Supervisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300096.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
